Faculty Bibliography

Subscapularis tenotomy for anatomic total shoulder arthroplasty has been the standard approach for shoulder surgeons that use the deltopectoral approach. The risk of subscapularis insufficiency after this approach has been well documented. In order to avoid subscapularis complications, subscapularis sparing approaches through the rotator interval have been developed. We present two alternative subscapularis preserving techniques that are performed through the deltopectoral interval and allow more complete osteophyte excision and accurate humeral head sizing. These techniques require modified instrumentation and are facilitated by the use of an adaptable prosthesis with dual eccentricity. Future studies will examine the comparative clinical and radiographic outcomes of these techniques.

Body Mass Index (BMI) is one of the metrics used to assess overall health and has been implicated in having predictive value in many aspects of health, including outcomes after shoulder replacement surgery. Outcome data from a multi- institutional database with an average follow-up period of 39.8 months (minimum 24-months) demonstrated that all patients, regardless of BMI, improved significantly after treatment with anatomic total shoulder arthroplasty (aTSA) or reverse total shoulder arthroplasty (rTSA). Improvements in outcomes were stratified and compared based upon BMI in three groups: less than 25, 25 to 35, and greater than 35. Comparing these measures demonstrated that aTSA patients with higher BMI were generally associated with lower functional postoperative outcome metric scores than aTSA patients with lower BMI, though the preoperative to postoperative gains were generally equivalent regardless of BMI. Interestingly, postoperative outcome metric scores with rTSA patients were equivalent regardless of BMI as were the pre-to-postoperative gains. Additionally, differences in the magnitude of pre-to-postoperative improvement of range of motion (ROM) measurements between patients of BMI less than 25 and BMI greater than 35 were noted for forward flexion, internal rotation, and active and passive external rotation. The actual clinical significance of these differences is unknown. Finally, patients with lower BMI appeared to have a higher incidence of low-grade scapular notching.

The use of reverse total shoulder arthroplasty (rTSA) in patients with posterior glenoid wear can be challenging. Implanting a baseplate in the correct version may require significant eccentric reaming, which further medializes the joint line and results in greater rotator cuff muscle shortening. To restore the joint line, bone graft may be required, though it is associated with additional risks. As an alternative solution, augmented glenoid baseplates offer the potential to restore the joint line and improve rotator cuff muscle tensioning without the need for eccentric reaming or supplemental bone graft. To that end, this computer analysis quantifies the rotator cuff muscle length for standard and augmented rTSA when used in a normal and posteriorly worn glenoid. These results demonstrate that shortening of the rotator cuff occurred for both the standard and posterior augmented reverse shoulder designs with additional muscle shortening occurring in scapula with posteriorly worn glenoids. More anatomic rotator cuff muscle tensioning was observed with augmented glenoid baseplates. The use of posterior augmented glenoid baseplates has the potential to improve stability and better restore active internal and external rotation, a current limitation of rTSA. However, clinical follow-up is necessary to confirm these favorable biomechanical results.

INTRODUCTION/BACKGROUND:The aim of this study was to evaluate the preliminary outcomes of a hybrid cage glenoid design in comparison to pegged all-polyethylene glenoid components in anatomic total shoulder arthroplasty (aTSA). MATERIALS AND METHODS/METHODS:Ninety-two patients undergoing primary anatomic total shoulder arthroplasty with minimum two-year follow-up were reviewed. Forty-six patients had an ultra-high molecular weight polyethylene (UHMWPE) cemented pegged glenoid component, and 46 had a hybrid cage glenoid component. Patient data was retrospectively reviewed from prospectively acquired data in a multi-institutional IRB approved database. These age, gender, and follow-up matched patients were evaluated and scored preoperatively and a latest follow-up using the SST, UCLA, ASES, Constant, and SPADI scoring metrics. Additional measures included active abduction, elevation, and external rotation. Radiolucent line assessment of the glenoid was performed by use of a Grashey and axillary radiograph at latest follow-up. A Student's two tailed, unpaired t-test was used to identify differences in preoperative and postoperative results, where p < 0.05 denoted a significant difference. RESULTS:All patients demonstrated significant improvements in pain and function following treatment with the primary aTSA. The database contained three complications for the aTSA patients with a cage glenoid, and three complications for patients with a UHMWPE pegged glenoid. Radiographic data was available for 37 of 46 cage glenoid patients and 29 of 46 UHMWPE pegged glenoid patients. Five of 37 cage glenoid patients had a radiolucent line (13.5%) with an average radiographic line score of 0.22. Eight of 29 UHMWPE peg glenoid patients had a radiolucent line (27.6%) with an average radiographic line score of 0.57. Cage aTSA patients were associated with significantly less blood loss than aTSA UHMWPE pegged glenoid patients (avg. blood loss = 242 vs. 337; p = 0.022). CONCLUSION/CONCLUSIONS:At minimum two-year follow-up, hybrid cage aTSA components show equal clinical outcomes to UHMWPE pegged glenoids. However, the hybrid cage components had significantly fewer radiolucent lines and less intra-operative blood loss. Additional and longer-term clinical and radiographic follow-up is necessary to confirm these promising early results.

INTRODUCTION/BACKGROUND:Indications for anatomic (aTSA) and reverse (rTSA) total shoulder arthroplasty are well defined and dependent on the function of the rotator cuff; however, indications for rTSA have gradually extended to complex fractures, revisions, and primary arthritis in very elderly patients. The risk of secondary rupture of a weakened or degenerative rotator cuff is difficult to assess and can lead the orthopaedic surgeon to hesitate between aTSA or rTSA. It, therefore, seems appropriate to compare these two types of prostheses in terms of pain, functional, clinical outcome metric scores, and complications, despite suspected differences between populations and the respective diseases. METHODOLOGY/METHODS:1,145 patients (69.2 ± 8.9 years) were treated by 12 orthopaedic surgeons in France and in the USA, using either aTSA or rTSA with one platform shoulder system. Five hundred twenty-eight patients received aTSA (66.2 ± 9.0 years; 283 female, 245 male) for treatment of degenerative arthritis, and 617 patients received rTSA (71.8 ± 8.0 years; 392 female, 225 male) for treatment of cuff tear arthroplasty, rotator cuff tear, and osteoarthritis. Each patient was scored preoperatively and at latest follow-up using the SST, UCLA, ASES, Constant, and SPADI metrics; active range of motion was also measured. The average follow-up for all patients was 39.7 ± 18.7 months (aTSA: 42.7 ± 21.9 months; rTSA: 37.1 ± 15.1 months). Improvements in outcome using each metric score were normalized on a 100 point scale, correlated, and compared. A Student's two-tailed, unpaired t-test was used to identify differences in preoperative, postoperative, and pre-to-postoperative improvements, where p < 0.05 denoted a significant difference. RESULTS:Preoperatively, rTSA patients had significantly lower mean outcome scores and significantly lower mean active range of motion as compared to aTSA patients. Post-operatively, rTSA and aTSA patients showed no significant difference in active forward flexion or in mean outcome scores as measured by four of the five metrics. rTSA patients had significantly lower active abduction, internal rotation, and active and passive external rotation than aTSA patients. However, they had significantly better strength (9.7 vs. 7.3 lbs, p < 0.0001). Preoperative to postoperative mean improvements were compared between both cohorts. rTSA patients were associated with significantly larger improvements in outcomes and also had significantly better improvements in active forward flexion and strength. Conversely, aTSA patients had significantly better improvement in active and passive external rotation and active internal rotation. Analysis of complications demonstrated a very similar rate between cohorts, with aTSA patients associated with a slightly lower rate (6.6 vs. 7.3%). CONCLUSION/CONCLUSIONS:This retrospective analysis of prospectively acquired data from 1,145 patients who received either a primary aTSA or rTSA prosthesis demonstrates that each device provides significant improvements with very similar mean results. In fact, the mean clinical outcomes associated with the reverse shoulder prostheses approach that of the "gold standard" anatomic device for their respective indications. Furthermore, the complication rates in this series are very similar and also favorable relative to the clinical literature. Findings, such as these, may at some point extend the indications of the reverse prosthesis to patients for whom an anatomical prosthesis could lead to a premature deterioration of the result.

INTRODUCTION: Paul Grammont's hemispherical gleno sphere concept medializes the center of rotation (CoR) to the glenoid face to increase deltoid abductor moment arms and improve muscle efficiency. Reducing glenosphere thickness to less than half its spherical radius further medializes the CoR and offers the potential for even greater improvements in efficiency. To that end, this study quantifies deltoid abducttor moment arms for six different rTSA prostheses during scapular abduction from 0 degrees to 140 degrees . METHODS: A 3D computer model was developed in Uni graphics to quantify deltoid moment arms during scapular abduction for the normal anatomic shoulder, the 36 mm Grammont Delta III (Depuy, Inc.), 36 mm BIO-RSA (R) (Tornier, Inc.), the 32 mm RSP(R) (DJO, Inc.), and the Equinoxe(R) rTSA (Exactech, Inc.) with three different glenosphere geometries: 38 mm x 21 mm, 46 mm x 25 mm, and the novel 46 mm x 21 mm. Each muscle was simulated as three lines from origin to insertion as the arm was elevated; positional data was exported to Matlab where the abductor moment arms were calculated for the anterior, middle, and posterior deltoid from 0 degrees to 140 degrees humeral abduction in the scapular plane using a 1.8:1 scapular rhythm. RESULTS: The 46 mm x 21 mm glenosphere had the larg est average abductor moment arms and also the largest efficiency for all three heads of the deltoid, having a 4.8% to 40.7% increase in the average deltoid efficiency relative to all other designs tested. The glenosphere design with the next most efficient deltoid was the 36 mm Delta III, which had the next most medialized CoR. The two least efficient designs were the BIO-RSA (R) and the DJO RSP(R) , which had the most lateral CoR. DISCUSSION: These results provide new biomechanical insights on the impact of glenosphere geometry on deltoid abductor moment arms and demonstrate that subtle changes in rTSA prosthesis design can result in dramatic improvements. Increasing glenosphere diameter while also decreasing thickness to be less than half its spherical radius may minimize the muscle forces required to perform activities of daily living. Clinical follow-up is necessary to demonstrate a reduction in complications related to joint over-loading and also demonstrate greater increases in range of motion for patients with weak musculature.

UNLABELLED:Many glenohumeral studies have demonstrated how anatomy varies across the population. Third and fourth generation shoulder prosthesis designs were developed to provide greater modularity and size ranges to better reproduce this anatomy and thus achieve better results in terms of shoulder function. This study quantifies the quality of anatomic reconstruction and compares that to long-term clinical outcomes using one fourth generation platform shoulder system. METHODOLOGY/METHODS:One hundred and forty primary total shoulder arthroplasties were performed by one experienced single surgeon between 2001 and 2009, using the same fourth generation modular prosthesis. Pre- and postoperative clinical assessments were quantified with the Constant, ASES, SPADI, SST, and UCLA scores, and active range of motion was measured. Five anatomic parameters were defined, measured, and compared pre- and postoperatively on the anterior-posterior (AP) radiographs: Humeral Head Height (HHH), Humeral Head Centering (HHC), Humeral Head Medial Offset (HHMO), Humeral Head Diameter (HHD), and Humeral Neck Angle (HNA). The differences between each of the parameters were then calculated and rated from 0 to 2 and then summed for each patient to obtain the Anatomic Reconstruction Index (ARI), which objectively quantifies and assesses the quality of the anatomic reconstruction. Patients were sorted based upon their ARI score into two groups (ARI 5 to 7 and ARI 8 to 10), and their latest follow-up outcomes were compared using the Mann-Whitney test to identify differences in preoperative and postoperative results, where p < 0.05 denoted a significant difference. RESULTS:Of the 140 primary prostheses performed, 78 patients were lost to follow-up, and 13 were excluded for complications that were not related to the anatomic reconstruction. Forty-nine patients (75.8 yrs., 31F/18M) were included with an average follow-up of 9.1 years. The average score for HHH was 1.9 ± 0.4, 1.8 ± 0.5 for HHC, 1.7 ± 0.5 for HHMO, 1.7 ± 0.5 for HHD, and 1.5 ± 0.7 for HNA. Thus, all reconstructions were rated good to excellent with 86% of very good/excellent reconstruction (ARI 8 to 10) and 14% good reconstruction (ARI 5 to 7). A comparison of radiographic anatomic parameters was performed for these two cohorts: HHC (< 0.0001), HNA (0.000), and ARI (<0.0001) were significantly greater for the ARI 8 to 10 cohort. Four of five postoperative clinical outcome metrics for the ARI 8 to 10 cohort were significantly greater than the mean values for the ARI 5 to 7 cohort. Additionally, mean postoperative pain on a daily basis and shoulder function for the ARI 8 to 10 cohort were significantly greater than that for the ARI 5 to 7 cohort. DISCUSSION/CONCLUSIONS:The relatively small number of good reconstructions (14%) compared to very good/excellent reconstructions (86%) and the absence of fair/poor reconstructions limited the ability for any strong linear correlations between anatomical reconstruction and clinical parameters. Despite this, patients with larger mean ARI scores were associated with significantly better outcomes for some measures. This study is limited by the use of 2D assessments from standard AP radiographs; this method can be further refined by the use of 3D quantitative assessment of each parameter. CONCLUSION/CONCLUSIONS:This study confirmed that an improved anatomic reconstruction results in better postoperative clinica outcomes. The fourth generation prosthesis used for this study allows continuous in-situ adjustment of the humeral head orientation through use of the spherical taper on the replicator plate and also a double adjustment of offset through the use of the offset humeral head and offset taper on the replicator plate.

INTRODUCTION/BACKGROUND:The rate of clinical improvement has never been studied after anatomic (aTSA) and reverse (rTSA) total shoulder arthroplasty. This study quantifies the rate of improvement after aTSA and rTSA using five different scoring metrics for 1,641 patients. METHODS:We evaluated 1,641 (69 ± 9.3 years old) patients treated by 14 orthopaedic surgeons using either aTSA or rTSA with a single platform shoulder system. Seven hundred twenty-nine patients received aTSA, and 912 patients received rTSA. Each patient was scored preoperatively and at various follow-up intervals (2 weeks, 6 weeks, 3 months, 6 months, annually, etc.) with a maximum follow-up time of 139 months using the SST, UCLA, ASES, Constant, and SPADI metrics. In addition, range of motion was measured. The rate of improvement was analyzed using a 40-point moving filter treadline over the entire range of follow-up. RESULTS:All metrics improved in a majority of patients with less than 5% worsening after 6 months. While gains in motion were present in the majority of patients after aTSA, a higher incidence of patients failed to experience improvement in range of motion after rTSA. Clinical worsening was seen in up to 10% and 20% of the visits for active flexion and abduction and external rotation, respectively. The majority of clinical improvement after aTSA and rTSA was noted in the first 6 months with full improvement noted by 12 to 24 months. During the first 12 months, the rate of improvement associated with rTSA patients was generally 30% larger than that of aTSA patients. DISCUSSION/CONCLUSIONS:The results of this large-scale database analysis demonstrate the reliability of improvements in outcomes and motion achieved with both aTSA and rTSA for various indications. For both aTSA and rTSA, less than 5% of patients reported worsening in each of the five clinical metrics after 6 months postoperative follow-up time. This study is significant because it quantifies how patient outcomes improve with time following treatment with both aTSA and rTSA. These results can be used to establish realistic patient expectations regarding the typical follow-up time required for pain to be reduced and function restored following surgical treatment with a total shoulder prosthesis.

INTRODUCTION: Achieving glenoid fixation with posterior bone loss can be challenging. The purpose of this study was to quantify the impact of two different sizes of posterior glenoid defects (10 degrees and 20 degrees ) on reverse shoulder arthroplasty (rTSA) glenoid baseplate fixation and determine if utilizing different sizes of posterior augmented baseplates (8 degrees and 16 degrees ) with off-axis reaming provides comparable fixation to using a standard baseplate with different amounts of eccentric reaming. METHODS: We quantified the impact of 10 degrees and 20 degrees posterior glenoid defects on rTSA baseplate fixation in composite scapulae using the ASTM F2028-14 rTSA glenoid loosening test method. Forty-two total implants (N = 7 for each size defect and for each type of baseplate) were tested at 750 N for 10,000 cycles. Baseplate displacement was measured before and after cyclic loading in the superior-inferior and anterior-posterior directions. Statistical analysis was performed with a two-tailed unpaired Student's t-test (significance defined as p < 0.05) to compare prosthesis displacements relative to each scapula (10 degrees and 20 degrees posterior defects for each type of baseplate versus the non-defect control) before and after cyclic loading. RESULTS: All glenoid baseplates remained well-fixed after cyclic loading in composite scapulae without a defect and in scapulae with posterior defects. Increased pre- and post-cyclic displacement was observed with increased posterior defect size and differences in displacement were observed between standard and augmented baseplates. Augmented baseplates were observed to remove significantly less bone than standard baseplates when correcting posterior defects, regardless of size. DISCUSSION: Both standard baseplates with eccentric reaming and two different sizes of augmented baseplates with off-axis reaming successfully maintained fixation following cyclic loading in composite scapula with corrected 10 degrees and 20 degrees posterior glenoid defects. Augmented glenoids may be more advantageous long-term from a fixation perspective as they preserve more subchondral glenoid bone due to the minimal reaming occurring by the off-axis method. Mid and long-term clinical follow-up comparisons of outcomes are necessary between these two techniques.